MLN8054, A Small Molecule Inhibitor of Aurora Kinase A, Sensitizes Androgen-Resistant Prostate Cancer to Radiation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MLN8054, A Small Molecule Inhibitor of Aurora Kinase A, Sensitizes Androgen-Resistant Prostate Cancer to Radiation

Published:2011-07 Issue:4 Volume:80 Page:1189-1197
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Moretti Luigi,Niermann Kenneth,Schleicher Stephen,Giacalone Nicholas J.,Varki Vinod,Kim Kwang Woon,Kopsombut Prapaporn,Jung Dae Kwang,Lu Bo

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference32 articles.

1. Management of advanced/metastatic prostate cancer: 2000 update;Hussain;Oncolo Gy (Williston Park),2000

2. Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells;Guan;Cancer Res,2007

3. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation;Zhou;Nat Genet,1998

4. Deletion of PSCA increases metastasis of TRAMP-induced prostate tumors without altering primary tumor formation;Moore;Prostate,2008

5. Aurora-A over-expression in high-grade PIN lesions and prostate cancer;Buschhorn;Prostate,2005

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitotic Kinase Inhibitors as Therapeutic Interventions for Prostate Cancer: Evidence from In Vitro Studies;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-12

2. Emerging roles of Aurora-A kinase in cancer therapy resistance;Acta Pharmaceutica Sinica B;2023-07

3. Aurora Kinases as Therapeutic Targets in Head and Neck Cancer;The Cancer Journal;2022-09

4. Identification of Ferroptosis-Related Genes in Laryngeal Carcinoma Using an Integrated Bioinformatics Approach;İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi;2022-08-29

5. Precision Oncology, Signaling, and Anticancer Agents in Cancer Therapeutics;Anti-Cancer Agents in Medicinal Chemistry;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3